Live from the NIH registry
Studies recruiting near Gainesville right now
Top 25 of 155 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Heart Failure, Acute Heart Failure
Phase 3
Interventional 5,200 participants sought
Duluth, GA Investigative Site 10083 — Duluth, Georgia (26.8 mi)
· Sponsor: Colorado Prevention Center
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — Gainesville, Georgia (0.6 mi)
· Sponsor: Akero Therapeutics, Inc
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Phase 3
Interventional 450 participants sought
Sl0044 50566 — Gainesville, Georgia (0.6 mi)
· Sponsor: UCB Biopharma SRL
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
C3G
Phase 3
Interventional 98 participants sought
Georgia Nephrology Research Inst — Lawrenceville, Georgia (24.8 mi)
· Sponsor: Novartis Pharmaceuticals
C-Brace Prospective Registry
Pareses, Lower Extremity
N/A
Observational 250 participants sought
ProCare Prosthetics x Ottobock.care — Buford, Georgia (15.4 mi)
· Sponsor: Otto Bock Healthcare Products GmbH
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
Type 2 Diabetes
Phase 2
Interventional 200 participants sought
Balanced Life Health Care Solutions/SKYCRNG — Lawrenceville, Georgia (24.8 mi)
· Sponsor: Eli Lilly and Company
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Phase 3
Interventional 4,500 participants sought
Teak Research Consults — Lawrenceville, Georgia (24.8 mi)
· Sponsor: Eli Lilly and Company
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Type 1 Diabetes Mellitus With Hypoglycemia
Phase 2
Interventional 186 participants sought
Physicians Research Associates LLC — Lawrenceville, Georgia (24.8 mi)
· Sponsor: Zucara Therapeutics Inc.
A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions
Narcolepsy Type 1
Phase 2, Phase 3
Interventional 500 participants sought
Georgia Neuro Center — Gainesville, Georgia (0.6 mi)
· Sponsor: Takeda
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Overweight, Obesity
Phase 3
Interventional 900 participants sought
Center for Advanced Research & Education — Gainesville, Georgia (0.6 mi)
· Sponsor: Eli Lilly and Company
Product Surveillance Registry
Cardiac Rhythm Disorders, Urological Disorders
N/A
Observational 100,000 participants sought
Research site — Gainesville, Georgia (0.6 mi)
· Sponsor: Medtronic
A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects
Iron Deficiency Anemia
Phase 3
Interventional 75 participants sought
Gwinnett Research Institute — Buford, Georgia (15.4 mi)
· Sponsor: AMAG Pharmaceuticals, Inc.
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
Phase 3
Interventional 3,680 participants sought
Emory Johns Creek Hospital — Johns Creek, Georgia (27.8 mi)
· Sponsor: National Cancer Institute (NCI)
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Alzheimers Disease
Phase 3
Interventional 800 participants sought
Center for Advanced Research & Education — Gainesville, Georgia (0.6 mi)
· Sponsor: Hoffmann-La Roche
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
Irritable Bowel Syndrome
Phase 2
Interventional 420 participants sought
GSK Investigational Site — Lawrenceville, Georgia (24.8 mi)
· Sponsor: GlaxoSmithKline
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Brain Cancer, Breast Cancer
N/A
Observational 7,000 participants sought
North Georgia Health System — Gainesville, Georgia (0.6 mi)
· Sponsor: Adela, Inc
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma
N/A
Observational 800 participants sought
Northeast Georgia Medical Center-Gainesville — Gainesville, Georgia (0.6 mi)
· Sponsor: University of Rochester
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Northeast Georgia Medical Ctr — Gainesville, Georgia (0.6 mi)
· Sponsor: Novo Nordisk A/S
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
Systemic Lupus Erythematosus
Phase 3
Interventional 550 participants sought
Parris and Associates Rheumatology — Lawrenceville, Georgia (24.8 mi)
· Sponsor: Novartis Pharmaceuticals
Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis
Vulvovaginal Candidiases, Vulvovaginal Candidiasis, Genital
Phase 3
Interventional 400 participants sought
One Health Research Clinic Inc. — Johns Creek, Georgia (27.8 mi)
· Sponsor: pH-D Feminine Health LLC
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma
Phase 3
Interventional 1,260 participants sought
Northside Hospital - Gwinnett — Lawrenceville, Georgia (24.8 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
Focal Segmental Glomerulosclerosis
Phase 2
Interventional 60 participants sought
Investigator Site # 1 — Lawrenceville, Georgia (24.8 mi)
· Sponsor: Akebia Therapeutics
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
Hypercholesterolemia
Phase 2
Interventional 420 participants sought
Center for Advanced Research and Education — Gainesville, Georgia (0.6 mi)
· Sponsor: Regeneron Pharmaceuticals
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Malignant Solid Neoplasm
N/A
Observational 2,062 participants sought
Northeast Georgia Medical Center-Gainesville — Gainesville, Georgia (0.6 mi)
· Sponsor: SWOG Cancer Research Network
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Non-small Cell Lung Cancer
Phase 2
Interventional 630 participants sought
Research Site — Gainesville, Georgia (0.6 mi)
· Sponsor: AstraZeneca